BR9810917A - Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador - Google Patents

Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador

Info

Publication number
BR9810917A
BR9810917A BR9810917-0A BR9810917A BR9810917A BR 9810917 A BR9810917 A BR 9810917A BR 9810917 A BR9810917 A BR 9810917A BR 9810917 A BR9810917 A BR 9810917A
Authority
BR
Brazil
Prior art keywords
polypeptide
isolated
antibody
pharmaceutical composition
produce
Prior art date
Application number
BR9810917-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul O Sheppard
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of BR9810917A publication Critical patent/BR9810917A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR9810917-0A 1997-07-18 1998-07-17 Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador BR9810917A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5315497P 1997-07-18 1997-07-18
PCT/US1998/014864 WO1999004000A1 (en) 1997-07-18 1998-07-17 Adipocyte-specific protein homologs

Publications (1)

Publication Number Publication Date
BR9810917A true BR9810917A (pt) 2000-08-15

Family

ID=21982287

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810917-0A BR9810917A (pt) 1997-07-18 1998-07-17 Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador

Country Status (18)

Country Link
US (2) US6265544B1 (enExample)
EP (1) EP1002075B1 (enExample)
JP (1) JP3762220B2 (enExample)
KR (1) KR100385868B1 (enExample)
CN (1) CN1201003C (enExample)
AT (1) ATE327328T1 (enExample)
AU (1) AU743745B2 (enExample)
BR (1) BR9810917A (enExample)
CA (1) CA2296530A1 (enExample)
DE (1) DE69834643T2 (enExample)
DK (1) DK1002075T3 (enExample)
ES (1) ES2264207T3 (enExample)
HU (1) HUP0003762A3 (enExample)
IL (1) IL134011A0 (enExample)
NO (1) NO20000215L (enExample)
PL (1) PL338139A1 (enExample)
RU (1) RU2218402C2 (enExample)
WO (1) WO1999004000A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1002075B1 (en) * 1997-07-18 2006-05-24 ZymoGenetics, Inc. Adipocyte-specific protein homologs
US6566499B1 (en) * 1997-07-18 2003-05-20 Zymogenetics, Inc. Adipocyte-specific protein homologs
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
US20030129691A1 (en) * 1998-02-09 2003-07-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7300774B1 (en) * 1999-12-09 2007-11-27 The Regents Of The University Of California Multimeric fusion proteins of the TNF superfamily ligands
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
HK1039892A1 (zh) * 1999-02-19 2002-05-17 Zymogenetics, Inc. 止血和免疫功能的抑制剂
US20050042719A1 (en) * 1999-05-27 2005-02-24 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp5
AU5037100A (en) * 1999-05-27 2000-12-18 Zymogenetics Inc. Adipocyte complement related protein homolog zacrp6
WO2000073444A1 (en) * 1999-05-27 2000-12-07 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp5
EP1953173B1 (en) * 1999-06-15 2009-11-18 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids endoding the same
WO2001002565A2 (en) * 1999-07-01 2001-01-11 Zymogenetics, Inc. Secreted protein zacrp4
DE19963859A1 (de) * 1999-12-30 2001-07-12 Apotech Res & Dev Ltd Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen
AU2001297656A1 (en) * 2000-11-29 2002-09-19 Zymogenetics, Inc. Adipocyte complement related protein zacrp11
US7348406B2 (en) 2001-01-16 2008-03-25 Serono Genetics Institute S.A. Metabolic gene polynucleotides and polypeptides and uses thereof
US7326678B2 (en) 2001-01-16 2008-02-05 Serono Genetics Institute S.A. GMG-3 GMG-4 and GMG-6 polynucleotides and polypeptides and uses thereof
CA2478675A1 (en) * 2002-03-08 2003-09-18 Zymogenetics, Inc. Inhibitors for use in hemostasis
EP1756159A1 (en) * 2004-05-21 2007-02-28 Xencor, Inc. C1q family member proteins with altered immunogenicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153480A1 (en) 1993-11-12 1995-06-01 Kenichi Matsubara Gene signature
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
EP1002075B1 (en) * 1997-07-18 2006-05-24 ZymoGenetics, Inc. Adipocyte-specific protein homologs
NZ522634A (en) * 1997-12-03 2004-02-27 Genentech Inc PRO243 encoding a polypeptide with homology to chordin and antibodies and vectors

Also Published As

Publication number Publication date
EP1002075B1 (en) 2006-05-24
RU2218402C2 (ru) 2003-12-10
HUP0003762A3 (en) 2005-11-28
DE69834643T2 (de) 2007-05-10
HUP0003762A2 (hu) 2001-08-28
JP3762220B2 (ja) 2006-04-05
KR100385868B1 (ko) 2003-06-02
KR20010021973A (ko) 2001-03-15
NO20000215D0 (no) 2000-01-17
EP1002075A1 (en) 2000-05-24
IL134011A0 (en) 2001-04-30
WO1999004000A1 (en) 1999-01-28
JP2001510045A (ja) 2001-07-31
NO20000215L (no) 2000-03-17
US20020156243A1 (en) 2002-10-24
AU8411398A (en) 1999-02-10
AU743745B2 (en) 2002-02-07
ES2264207T3 (es) 2006-12-16
US6265544B1 (en) 2001-07-24
PL338139A1 (en) 2000-09-25
CN1201003C (zh) 2005-05-11
CA2296530A1 (en) 1999-01-28
ATE327328T1 (de) 2006-06-15
DE69834643D1 (de) 2006-06-29
CN1272883A (zh) 2000-11-08
DK1002075T3 (da) 2006-09-18
US6518403B2 (en) 2003-02-11

Similar Documents

Publication Publication Date Title
BR9810917A (pt) Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador
Feramisco Microinjection of fluorescently labeled α-actinin into living fibroblasts
Beyer et al. Two lactose binding lectins from chicken tissues. Purified lectin from intestine is different from those in liver and muscle.
Merenmies et al. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane.
DE69834334D1 (de) Für adipozyten spezifische protein homologe
Schwyter et al. Subtilisin cleavage of actin inhibits in vitro sliding movement of actin filaments over myosin.
Murphy et al. Clathrin assembly protein AP-3: The identity of the 155K protein, AP 180, and NP185 and demonstration of a clathrin binding domain
Hisanaga et al. Dephosphorylation-induced interactions of neurofilaments with microtubules.
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
Denhez et al. Syndesmos, a syndecan-4 cytoplasmic domain interactor, binds to the focal adhesion adaptor proteins paxillin and Hic-5
BR0008772A (pt) Polipeptìdeo isolado, proteìna de fusão, molécula de polinucleotìdeo isolado, vetor de expressão, célula cultivada, anticorpo, processos para produzir uma proteìna e um anticorpo para um polipeptìdeo, para estimular uma resposta imunológica em um mamìfero, para expandir células hematopoiéticas e progenitores de células hematopoiéticas, para reduzir a proliferação de células b ou t neoplásicas e para detectar a presença de rna de ligando zalfa11 e de ligando zalfal11 em uma amostra biológica
DE69536123D1 (de) Fusionsprotein dass bpTK7 enthält
ATE151113T1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
Nakai et al. Transformation of BALB/3T3 cells by simian virus 40 causes a decreased synthesis of a collagen-binding heat-shock protein (hsp47).
Javaherian et al. Laminin modulates morphogenic properties of the collagen XVIII endostatin domain
BR9407512A (pt) Sequência de ácidos nucléicos vírus recombinante defectivo vetor notadamente virale composição farmaceutica e utilização de uma sequencia de ácidos nucléicos
ATE372384T1 (de) Protein-tyrosin-phosphatase ptp-s31
Kuhlman et al. Purification and characterization of an α1β2 isoform of CapZ from human erythrocytes: cytosolic location and inability to bind to Mg2+ ghosts suggest that erythrocyte actin filaments are capped by adducin
Isaacs et al. Association of titin and myosin heavy chain in developing skeletal muscle.
BR9913942A (pt) Polinucleotìdeo e polipeptìdeo isolado, vetor de expressão, célula cultivada, constructo de dna codificador de uma proteìna de fusão, processos de produção de uma proteìna, de fusão de um polipeptìdeo e de um anticorpo para o polipeptìdeo e de detecção, em uma amostra de teste, da presença de um modulador da atividade da proteìna zalpha11 e de um ligante de receptor zalpha11 dentro de uma amostra de teste, e, anticorpo
Kumagai et al. Disulfide-bonding between Drosophila laminin β and γ chains is essential for α chain to form αβγ trimer
Rüdiger et al. Differential actin organization by vinculin isoforms: implications for cell type-specific microfilament anchorage
Jørgensen et al. Polypeptide binding properties of the chaperone calreticulin
Howe et al. Structural analysis of three subunits of laminin from teratocarcinoma-derived parietal endoderm cells

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART 36 DA LPI (LEI 9.279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.